BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16636064)

  • 1. The estrogen-responsive B box protein is a novel regulator of the retinoid signal.
    Cheung BB; Bell J; Raif A; Bohlken A; Yan J; Roediger B; Poljak A; Smith S; Lee M; Thomas WD; Kavallaris M; Norris M; Haber M; Liu HL; Zajchowski D; Marshall GM
    J Biol Chem; 2006 Jun; 281(26):18246-56. PubMed ID: 16636064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation.
    Raif A; Marshall GM; Bell JL; Koach J; Tan O; D'andreti C; Thomas W; Sekyere E; Norris M; Haber M; Kavallaris M; Cheung BB
    Cancer Lett; 2009 May; 277(1):82-90. PubMed ID: 19147277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.
    Cheung B; Yan J; Smith SA; Nguyen T; Lee M; Kavallaris M; Norris MD; Haber M; Marshall GM
    Int J Cancer; 2003 Jul; 105(6):856-67. PubMed ID: 12767074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells.
    Lin B; Chen GQ; Xiao D; Kolluri SK; Cao X; Su H; Zhang XK
    Mol Cell Biol; 2000 Feb; 20(3):957-70. PubMed ID: 10629053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation.
    Beer HD; Munding C; Dubois N; Mamie C; Hohl D; Werner S
    J Biol Chem; 2002 Jun; 277(23):20740-9. PubMed ID: 11919186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of retinoic acid and 8-chloro-adenosine 3',5'-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: involvement of mitochondria.
    Srivastava RK; Srivastava AR; Cho-Chung YS; Longo DL
    Clin Cancer Res; 1999 Jul; 5(7):1892-904. PubMed ID: 10430097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.
    Suzui M; Shimizu M; Masuda M; Lim JT; Yoshimi N; Weinstein IB
    Mol Cancer Ther; 2004 Mar; 3(3):309-16. PubMed ID: 15026551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
    Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
    Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant.
    Liu HL; Golder-Novoselsky E; Seto MH; Webster L; McClary J; Zajchowski DA
    Mol Endocrinol; 1998 Nov; 12(11):1733-48. PubMed ID: 9817599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein.
    Ng AP; Nin DS; Fong JH; Venkataraman D; Chen CS; Khan M
    Mol Cancer Ther; 2007 Aug; 6(8):2240-8. PubMed ID: 17699721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
    Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
    J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion proteins of retinoid receptors antagonize TGF-beta-induced growth inhibition of lung epithelial cells.
    La P; Morgan TA; Sykes SM; Mao H; Schnepp RW; Petersen CD; Hua X
    Oncogene; 2003 Jan; 22(2):198-210. PubMed ID: 12527889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells.
    Wu Q; Chen ZM; Su WJ
    Int J Biochem Cell Biol; 2002 Sep; 34(9):1102-14. PubMed ID: 12009305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
    J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
    Zhu G
    Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
    Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
    J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.